MPV 1248

Known as: MPV-1248 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-2000
01219862000

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
To investigate the usefulness of atipamezole [MPV-1248, 4-(2-ethyl-2, 3-dihydro-1H-inden-2-yl)-1H-imidazole], a novel alpha(2… (More)
Is this relevant?
1992
1992
Atipamezole (MPV-1248, 4-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole), a potent alpha 2-adrenoceptor antagonist, was… (More)
Is this relevant?
1990
1990
1. Single doses (10, 30 and 100 mg) of atipamezole (MPV-1248), a new potent and selective imidazole-type alpha 2-adrenoceptor… (More)
Is this relevant?
1990
1990
The role of alpha 2-adrenoceptors in the regulation of basal prolactin secretion was investigated in healthy male volunteers. Two… (More)
Is this relevant?
1989
1989
The potency, selectivity and specificity of atipamezole [MPV-1248, 4-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole], as an… (More)
Is this relevant?
1989
1989
The anesthetic-reducing property of medetomidine far exceeds that seen with other alpha 2-adrenergic agonists (e.g., clonidine… (More)
Is this relevant?
1988
1988
The effects of antipamezole (MPV-1248), a novel selective and specific alpha 2-adrenoceptor antagonist, were studied on monoamine… (More)
Is this relevant?
1986
1986
The changes of free 3-methoxy-4-hydroxyphenylglycol (MHPG) in cerebrospinal fluid (CSF) were compared with the corresponding… (More)
Is this relevant?